Position in ROIV
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$2,268,962
+$512,695 QoQ
Shares Held
81,912
+1.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NISA INVESTMENT ADVISORS, LLC holds $80,190,121 across 241 Biotechnology names. ROIV ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,183 | $25,981,036 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,771 | $15,275,865 | |
| 3 | EXEL |
Exelixis, Inc.
|
107,496 | $4,610,503 | |
| 4 | TECH |
BIO-TECHNE Corp
|
72,813 | $3,805,207 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,357 | $3,095,950 | |
| 6 | INCY |
Incyte Corp
|
31,835 | $2,996,310 | |
| 7 | ROIV |
Roivant Sciences Ltd.
This page
|
81,912 | $2,268,962 | |
| 8 | INSM |
INSMED Inc
|
13,447 | $2,198,853 |
All Filings in ROIV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,268,962 | 81,912 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,756,267 | 80,934 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $16,869 | 1,115 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $12,566 | 1,115 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $21,017 | 2,083 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $11,297 | 955 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,308 | 200 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $792 | 75 | Shares | Sole | 2024-07-19 | |
| No filing history on record for this holder in this stock. | ||||||